Preimplantation Genetic Testing Market Is Predicted To Surpass 541.8 Million USD by 2022

CITY – Northbrook , Country – USA, 2020-Feb-12 — /EPR Network/ —

The global preimplantation genetic testing market is projected to register a CAGR of 10.0% from 2017 to 2022. The rising infertility rate across the world is the key factor driving the growth of the market. Geographically, this market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Browse 85 Market Data Tables and 42 Figures spread through 204 Pages and in-depth TOC on “Preimplantation Genetic Testing Market – Global Forecast to 2022”

The global preimplantation genetic testing market is segmented by technology, product & service, procedure type, applications, end user and region. Based on technology, the market is segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP). The NGS segment is expected to grow at a faster rate owing to the increasing applications of preimplantation genetic testing for different cancer cases.

Browse In-depth Insights: https://www.marketsandmarkets.com/Market-Reports/preimplantation-genetic-testing-market-605.html

The global preimplantation genetic testing market, by product & service, is segmented into instruments, reagents & consumables, and software & services. The reagents & consumables segment accounted for the largest share of the global preimplantation testing market in 2016. The large share of this segment can be attributed to the expanding application horizons of specific technologies (such as NGS and aCGH for whole-genome sequencing and FISH in the diagnosis of specific genetic disorders) and rising number of probe-based multiplex genetic analysis.

In 2016, North America accounted for the largest share of the market due to factors such as rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS), and increasing private-public funding to develop and commercialize novel PGS & PGD procedures. However, the Asia-Pacific region is expected to register the highest CAGR during the forecast period. Growth in this market is attributed to the growing number of ART & IVF procedures in the region, continuous decline in average fertility rate, and growing medical tourism across APAC countries.

Geographically, the preimplantation genetic testing market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe.

As of 2016, the major product manufacturers operating in the global market included Illumina, Inc. (U.S.), CooperSurgical, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abbott Laboratories (U.S.), Natera, Inc. (U.S.), Rubicon Genomics, Inc. (U.S.), Oxford Gene Technology (U.K.), Yikon Genomics (China), and SciGene Corporation (U.S.), among others. Moreover, as of 2016, major service providers active in the global market included Beijing Genomics Institute (BGI) (China), Good Start Genetics (U.S.), CombiMatrix Corporation (U.S.), Genea Limited (Australia), Invicta Genetics (Poland), and Progenesis (U.S.).

Stakeholders

• Preimplantation Genetic Diagnosis and Screening Product Manufacturing Companies
• Preimplantation Genetic Diagnosis and Screening Service Providers
• Suppliers/Distributors
• Fertility Clinics and Maternity Centers
• Clinical Research Organizations (CROs)

Scope of the Report

Preimplantation Genetic Testing Industry By Region:

• North America
• Europe
• Asia-Pacific
• Rest of the World (ROW)

Request For Custom Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=605

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. 

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com